Surgical Gloves Market (By Product: Neoprene, Nitrile, Natural Rubber, Polyisoprene, Others; By Sterility: Sterile Gloves, Non- Sterile Gloves; By Form: Powder-free, Powder; By End-use: Dental, Veterinary, Emergency medical service, Hospital, Others; By Usage: Reusable, Disposable) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Surgical Gloves Market
5.1. COVID-19 Landscape: Surgical Gloves Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Surgical Gloves Market, By Product
8.1. Surgical Gloves Market Revenue and Volume, by Product, 2024-2033
8.1.1. Neoprene
8.1.1.1. Market Revenue and Volume Forecast (2021-2033)
8.1.2. Nitrile
8.1.2.1. Market Revenue and Volume Forecast (2021-2033)
8.1.3. Natural Rubber
8.1.3.1. Market Revenue and Volume Forecast (2021-2033)
8.1.4. Polyisoprene
8.1.4.1. Market Revenue and Volume Forecast (2021-2033)
8.1.5. Others
8.1.5.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 9. Global Surgical Gloves Market, By Sterility
9.1. Surgical Gloves Market Revenue and Volume, by Sterility, 2024-2033
9.1.1. Sterile Gloves
9.1.1.1. Market Revenue and Volume Forecast (2021-2033)
9.1.2. Non- Sterile Gloves
9.1.2.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 10. Global Surgical Gloves Market, By Form
10.1. Surgical Gloves Market Revenue and Volume, by Form, 2024-2033
10.1.1. Powder-free
10.1.1.1. Market Revenue and Volume Forecast (2021-2033)
10.1.2. Powder
10.1.2.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 11. Global Surgical Gloves Market, By End-use
11.1. Surgical Gloves Market Revenue and Volume, by End-use, 2024-2033
11.1.1. Dental
11.1.1.1. Market Revenue and Volume Forecast (2021-2033)
11.1.2. Veterinary
11.1.2.1. Market Revenue and Volume Forecast (2021-2033)
11.1.3. Emergency medical service
11.1.3.1. Market Revenue and Volume Forecast (2021-2033)
11.1.4. Hospital
11.1.4.1. Market Revenue and Volume Forecast (2021-2033)
11.1.5. Others
11.1.5.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 12. Global Surgical Gloves Market, By Usage
12.1. Surgical Gloves Market Revenue and Volume, by Usage, 2024-2033
12.1.1. Reusable
12.1.1.1. Market Revenue and Volume Forecast (2021-2033)
12.1.2. Disposable
12.1.2.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 13. Global Surgical Gloves Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.1.2. Market Revenue and Volume Forecast, by Sterility (2021-2033)
13.1.3. Market Revenue and Volume Forecast, by Form (2021-2033)
13.1.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.1.5. Market Revenue and Volume Forecast, by Usage (2021-2033)
13.1.6. U.S.
13.1.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.1.6.2. Market Revenue and Volume Forecast, by Sterility (2021-2033)
13.1.6.3. Market Revenue and Volume Forecast, by Form (2021-2033)
13.1.6.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.1.6.5. Market Revenue and Volume Forecast, by Usage (2021-2033)
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.1.7.2. Market Revenue and Volume Forecast, by Sterility (2021-2033)
13.1.7.3. Market Revenue and Volume Forecast, by Form (2021-2033)
13.1.7.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.1.7.5. Market Revenue and Volume Forecast, by Usage (2021-2033)
13.2. Europe
13.2.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.2.2. Market Revenue and Volume Forecast, by Sterility (2021-2033)
13.2.3. Market Revenue and Volume Forecast, by Form (2021-2033)
13.2.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.2.5. Market Revenue and Volume Forecast, by Usage (2021-2033)
13.2.6. UK
13.2.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.2.6.2. Market Revenue and Volume Forecast, by Sterility (2021-2033)
13.2.6.3. Market Revenue and Volume Forecast, by Form (2021-2033)
13.2.7. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.2.8. Market Revenue and Volume Forecast, by Usage (2021-2033)
13.2.9. Germany
13.2.9.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.2.9.2. Market Revenue and Volume Forecast, by Sterility (2021-2033)
13.2.9.3. Market Revenue and Volume Forecast, by Form (2021-2033)
13.2.10. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.2.11. Market Revenue and Volume Forecast, by Usage (2021-2033)
13.2.12. France
13.2.12.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.2.12.2. Market Revenue and Volume Forecast, by Sterility (2021-2033)
13.2.12.3. Market Revenue and Volume Forecast, by Form (2021-2033)
13.2.12.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.2.13. Market Revenue and Volume Forecast, by Usage (2021-2033)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.2.14.2. Market Revenue and Volume Forecast, by Sterility (2021-2033)
13.2.14.3. Market Revenue and Volume Forecast, by Form (2021-2033)
13.2.14.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.2.15. Market Revenue and Volume Forecast, by Usage (2021-2033)
13.3. APAC
13.3.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.3.2. Market Revenue and Volume Forecast, by Sterility (2021-2033)
13.3.3. Market Revenue and Volume Forecast, by Form (2021-2033)
13.3.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.3.5. Market Revenue and Volume Forecast, by Usage (2021-2033)
13.3.6. India
13.3.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.3.6.2. Market Revenue and Volume Forecast, by Sterility (2021-2033)
13.3.6.3. Market Revenue and Volume Forecast, by Form (2021-2033)
13.3.6.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.3.7. Market Revenue and Volume Forecast, by Usage (2021-2033)
13.3.8. China
13.3.8.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.3.8.2. Market Revenue and Volume Forecast, by Sterility (2021-2033)
13.3.8.3. Market Revenue and Volume Forecast, by Form (2021-2033)
13.3.8.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.3.9. Market Revenue and Volume Forecast, by Usage (2021-2033)
13.3.10. Japan
13.3.10.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.3.10.2. Market Revenue and Volume Forecast, by Sterility (2021-2033)
13.3.10.3. Market Revenue and Volume Forecast, by Form (2021-2033)
13.3.10.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.3.10.5. Market Revenue and Volume Forecast, by Usage (2021-2033)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.3.11.2. Market Revenue and Volume Forecast, by Sterility (2021-2033)
13.3.11.3. Market Revenue and Volume Forecast, by Form (2021-2033)
13.3.11.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.3.11.5. Market Revenue and Volume Forecast, by Usage (2021-2033)
13.4. MEA
13.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.4.2. Market Revenue and Volume Forecast, by Sterility (2021-2033)
13.4.3. Market Revenue and Volume Forecast, by Form (2021-2033)
13.4.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.4.5. Market Revenue and Volume Forecast, by Usage (2021-2033)
13.4.6. GCC
13.4.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.4.6.2. Market Revenue and Volume Forecast, by Sterility (2021-2033)
13.4.6.3. Market Revenue and Volume Forecast, by Form (2021-2033)
13.4.6.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.4.7. Market Revenue and Volume Forecast, by Usage (2021-2033)
13.4.8. North Africa
13.4.8.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.4.8.2. Market Revenue and Volume Forecast, by Sterility (2021-2033)
13.4.8.3. Market Revenue and Volume Forecast, by Form (2021-2033)
13.4.8.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.4.9. Market Revenue and Volume Forecast, by Usage (2021-2033)
13.4.10. South Africa
13.4.10.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.4.10.2. Market Revenue and Volume Forecast, by Sterility (2021-2033)
13.4.10.3. Market Revenue and Volume Forecast, by Form (2021-2033)
13.4.10.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.4.10.5. Market Revenue and Volume Forecast, by Usage (2021-2033)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.4.11.2. Market Revenue and Volume Forecast, by Sterility (2021-2033)
13.4.11.3. Market Revenue and Volume Forecast, by Form (2021-2033)
13.4.11.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.4.11.5. Market Revenue and Volume Forecast, by Usage (2021-2033)
13.5. Latin America
13.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.5.2. Market Revenue and Volume Forecast, by Sterility (2021-2033)
13.5.3. Market Revenue and Volume Forecast, by Form (2021-2033)
13.5.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.5.5. Market Revenue and Volume Forecast, by Usage (2021-2033)
13.5.6. Brazil
13.5.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.5.6.2. Market Revenue and Volume Forecast, by Sterility (2021-2033)
13.5.6.3. Market Revenue and Volume Forecast, by Form (2021-2033)
13.5.6.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.5.7. Market Revenue and Volume Forecast, by Usage (2021-2033)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.5.8.2. Market Revenue and Volume Forecast, by Sterility (2021-2033)
13.5.8.3. Market Revenue and Volume Forecast, by Form (2021-2033)
13.5.8.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.5.8.5. Market Revenue and Volume Forecast, by Usage (2021-2033)
Chapter 14. Company Profiles
14.1. Cardinal Health Inc.
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. MRK Healthcare Pvt. Ltd.
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Sempermed
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Globus Group
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Kanam Latex Industries Pvt. Ltd.
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Narang Medical Limited
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Hartalega Holdings
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Top Glove Corporation
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Ansell Ltd.
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Sun Healthcare (M) Sdn. Bhd
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client